Angioedema Treatment Market Growth Through 2030 Creates New Strategic Opportunities
Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Angioedema Treatment Market Expansion From $3.59 Billion In 2026 To $6.18 Billion In 2030
In recent years, the angioedema treatment market has experienced swift expansion, climbing from $3.13 billion in 2025 to $3.59 billion in 2026, reflecting a robust compound annual growth rate (CAGR) of 14.8%. Historical growth was driven by factors such as emergency allergy management, hospital-based care, corticosteroid usage, the availability of antihistamines, and a limited arsenal of targeted therapies.
The angioedema treatment market is projected to experience significant expansion in the coming years, reaching an estimated value of $6.18 billion by 2030, with a compound annual growth rate (CAGR) of 14.5%. This anticipated growth during the forecast period is driven by factors such as the development of biologic drugs, the rise of genetic testing, the establishment of specialized allergy clinics, enhanced patient education, and a stronger emphasis on preventive care. Key trends shaping this period include the growing adoption of targeted bradykinin therapies, the advancement of treatments for hereditary angioedema, the broadening of emergency treatment protocols, heightened diagnostic awareness, and a concentrated effort on preventive therapies.
Download A Free Sample Report For Comprehensive Market Insights:
Angioedema Treatment Market Growth Drivers: What Factors Are Accelerating Expansion?
A growing prevalence of rare diseases is anticipated to drive expansion in the angioedema treatment market moving forward. These rare diseases are health conditions affecting only a tiny fraction of the population, frequently characterized by scarce therapeutic options and substantial health consequences. Their increasing occurrence stems from progress in genetic testing and diagnostic tools, which allow medical professionals to identify and accurately diagnose conditions that were previously overlooked, thereby raising the reported rate of prevalence. Angioedema treatments play a beneficial role in conditions like hereditary angioedema by offering targeted therapies for preventing and controlling severe swelling episodes, thus enhancing patient outcomes. As an example, the Food and Drug Administration, a U.S. federal agency, reported in November 2024 that over 7,000 rare diseases affected more than 30 million people in the United States. Consequently, the rising incidence of rare diseases is fueling growth in the angioedema treatment market.
Angioedema Treatment Market Segment Landscape And Growth Potential
The angioedema treatment market covered in this report is segmented –
1) By Type: Allergic Angioedema, Drug-Induced Angioedema, Idiopathic Angioedema, Hereditary Angioedema
2) By Route Of Administration: Injection, Oral
3) By End Use: Hospitals, Clinics, Research Organizations
Subsegments:
1) By Allergic Angioedema: Antihistamines, Corticosteroids, Epinephrine, Immunotherapy, Allergen Avoidance Therapies
2) By Drug-Induced Angioedema: Discontinuation of Causative Drug, Antihistamines, Corticosteroids, Epinephrine, Bradykinin Pathway Inhibitors
3) By Idiopathic Angioedema: Empirical Antihistamine Therapy, Corticosteroid Therapy, Leukotriene Receptor Antagonists, Monoclonal Antibodies, Observation and Symptom Management
4) By Hereditary Angioedema: C1 Esterase Inhibitor Replacement Therapy, Bradykinin B2 Receptor Antagonists, Kallikrein Inhibitors, Attenuated Androgens, Antifibrinolytics
Angioedema Treatment Market Trends: What Is Shaping Future Industry Growth?
Leading players in the angioedema treatment market are actively developing innovative approaches, specifically subcutaneous injections, designed to deliver faster and more convenient relief for individuals with acute hereditary angioedema (HAE) attacks. This delivery technique involves administering medication directly into the fatty layer beneath the skin, facilitating gradual and consistent absorption into the bloodstream. A notable example occurred in April 2025, when CSL Limited, a biotechnology firm based in Australia, introduced ANDEMBRY (garadacimab)—a novel, fully human monoclonal antibody aimed at preventing acute episodes in hereditary angioedema (HAE) patients. As the first pre-filled pen for once-monthly subcutaneous use, ANDEMBRY provides a practical option for long-term prophylaxis. Its mechanism of action involves blocking activated Factor XII (Factor XIIa), a crucial trigger in the cascade that initiates angioedema. This development marks a substantial step forward in HAE management, offering effective, patient-focused disease control.
Angioedema Treatment Market Competitive Landscape: Who Are The Leading Companies?
Major companies operating in the angioedema treatment market are Sanofi SA, Takeda Pharmaceutical Company Limited, Viatris Inc., Otsuka Pharmaceutical Co. Ltd., Fresenius Kabi AG, Bausch Health Companies Inc., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd, Cipla Inc., Alnylam Pharmaceuticals Inc, Ionis Pharmaceuticals Inc., Salix Pharmaceuticals Ltd, BioCryst Pharmaceuticals Inc., Pharming Group NV, Pharvaris Netherlands B.V, Astria Therapeutics, Intellia Therapeutics, KalVista Pharmaceuticals Ltd., ADARx Pharmaceuticals, Adverum Biotechnologies Inc.
Access The Complete Angioedema Treatment Market Report:
Angioedema Treatment Market Leading Geography: Which Region Generates The Most Revenue?
North America was the largest region in the angioedema treatment market in 2025. The regions covered in the angioedema treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
